Atai Life Sciences N.V. (NQ: ATAI )

10.86 USD -0.13 (-1.18%)

Streaming Delayed Price Updated: 10:36 AM EST, Nov 30, 2021 Add to My Watchlist

Price and Volume

Volume	121,395
Open	11.18
Bid (Size)	10.80 (2)
Ask (Size)	10.84 (2)
Prev. Close	10.99
Today's Range	10.79 - 11.27
52wk Range	10.45 - 22.91
Shares Outstanding	N/A
Dividend Yield	55.25%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Use of Ketamine for Mental Disorders Rising While New Therapies Emerge

November 17, 2021

Increasing Prevalence of Depression & Mental Health Disorders Fueling Huge Growth in Psychedelic Drugs Market

November 04, 2021

Performance

YTD	-44.16%	-44.16%
1 Month	-30.03%	-30.03%
3 Month	-31.83%	-31.83%
6 Month	-44.16%	-44.16%
1 Year	-44.16%	-44.16%

More News

Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention

October 27, 2021

Analyst Ratings For ATAI Life Sciences

Today 11:51 EST

Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways

November 29, 2021

NetworkNewsAudio – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers Hope on the Smoking-Cessation Horizon

November 04, 2021

Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and More

November 01, 2021

Analyst Ratings For ATAI Life Sciences

November 11, 2021

Psychedelic Drug Stocks Continued To Decline Last Week

November 21, 2021

Psychedelic Drug Stocks Have Plunged -10.6%, On Average, So Far In November

November 14, 2021

Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others

November 11, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

The Borger News-Herald

Atai Life Sciences N.V. (NQ: ATAI )

Price and Volume

Top News

Performance

More News